Seegnal Inc. Closes First Tranche and Upsizes Private Placement to CDN$1.85 Million

Seegnal Inc. (TSXV: SEGN), a clinical decision support software company, has completed the first phase of a private funding round. Stratford Beacon Herald reports the company increased the total offering to CDN$1,850,000 and extended the deadline for the second tranche to September 30, 2026.
The company plans to use the proceeds for general corporate operations and working capital. Insiders participated in the expanded offering, which required special regulatory approval under minority shareholder protection rules.
Brantford Expositor reports Seegnal successfully closed its first tranche of the non-brokered private placement. The TSX Venture Exchange approved an expansion of the offering to CDN$1,850,000, split across up to 6,607,143 units. The second tranche must close by September 30, 2026.
Company insiders bought units in the expanded offering. Market Screener notes this participation qualifies as a related party transaction under Multilateral Instrument 61-101. This rule protects minority shareholders in special deals involving company executives and controlling shareholders.
The Province confirms Seegnal will direct the raised capital toward general corporate expenses and working capital needs. The company offers SaaS-based clinical decision support tools globally. This funding provides runway to expand operations and support its platform development.
Publishers
16
Articles
15
Reach
16